FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092804594> ?p ?o ?g. }

• W3092804594 abstract "The limits of radiation tolerance, which often deter the use of large doses, have been a major challenge to the treatment of bulky primary and metastatic cancers. A novel technique using spatial modulation of megavoltage therapy beams, commonly referred to as spatially fractionated radiation therapy (SFRT) (e.g., GRID radiation therapy), which purposefully maintains a high degree of dose heterogeneity across the treated tumor volume, has shown promise in clinical studies as a method to improve treatment response of advanced, bulky tumors. Compared to conventional uniform-dose radiotherapy, the complexities of megavoltage GRID therapy include its highly heterogeneous dose distribution, very high prescription doses, and the overall lack of experience among physicists and clinicians. Since only a few centers have used GRID radiation therapy in the clinic, wide and effective use of this technique has been hindered. To date, the mechanisms underlying the observed high tumor response and low toxicity are still not well understood. To advance SFRT technology and planning, the Physics Working Group of the Radiosurgery Society (RSS) GRID/Lattice, Microbeam and Flash Radiotherapy Working Groups, was established after an RSS-NCI Workshop. One of the goals of the Physics Working Group was to develop consensus recommendations to standardize dose prescription, treatment planning approach, response modeling and dose reporting in GRID therapy. The objective of this report is to present the results of the Physics Working Group's consensus that includes recommendations on GRID therapy as an SFRT technology, field dosimetric properties, techniques for generating GRID fields, the GRID therapy planning methods, documentation metrics and clinical practice recommendations. Such understanding is essential for clinical patient care, effective comparisons of outcome results, and for the design of rigorous clinical trials in the area of SFRT. The results of well-conducted GRID radiation therapy studies have the potential to advance the clinical management of bulky and advanced tumors by providing improved treatment response, and to further develop our current radiobiology models and parameters of radiation therapy design." @default.
• W3092804594 created "2020-10-22" @default.
• W3092804594 creator A5000702766 @default.
• W3092804594 creator A5023779644 @default.
• W3092804594 creator A5036656612 @default.
• W3092804594 creator A5044617172 @default.
• W3092804594 creator A5060298788 @default.
• W3092804594 creator A5060952463 @default.
• W3092804594 creator A5061274866 @default.
• W3092804594 creator A5067536094 @default.
• W3092804594 creator A5070908847 @default.
• W3092804594 creator A5073948949 @default.
• W3092804594 creator A5085287368 @default.
• W3092804594 date "2020-10-19" @default.
• W3092804594 modified "2023-10-16" @default.
• W3092804594 title "Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group" @default.
• W3092804594 cites W1186275539 @default.
• W3092804594 cites W1976996553 @default.
• W3092804594 cites W1981050334 @default.
• W3092804594 cites W1988896654 @default.
• W3092804594 cites W1995732232 @default.
• W3092804594 cites W2008241039 @default.
• W3092804594 cites W2008666837 @default.
• W3092804594 cites W2016866011 @default.
• W3092804594 cites W2018895767 @default.
• W3092804594 cites W2020136386 @default.
• W3092804594 cites W2023646003 @default.
• W3092804594 cites W2033649139 @default.
• W3092804594 cites W2037716707 @default.
• W3092804594 cites W2044664181 @default.
• W3092804594 cites W2051885426 @default.
• W3092804594 cites W2054217185 @default.
• W3092804594 cites W2061878613 @default.
• W3092804594 cites W2063787045 @default.
• W3092804594 cites W2067302262 @default.
• W3092804594 cites W2079093819 @default.
• W3092804594 cites W2080581240 @default.
• W3092804594 cites W2081852424 @default.
• W3092804594 cites W2087237999 @default.
• W3092804594 cites W2087611599 @default.
• W3092804594 cites W2087678541 @default.
• W3092804594 cites W2109194299 @default.
• W3092804594 cites W2113849825 @default.
• W3092804594 cites W2139327810 @default.
• W3092804594 cites W2158482032 @default.
• W3092804594 cites W2167454362 @default.
• W3092804594 cites W2176120445 @default.
• W3092804594 cites W2180298749 @default.
• W3092804594 cites W2327032437 @default.
• W3092804594 cites W2621902175 @default.
• W3092804594 cites W2738335906 @default.
• W3092804594 cites W2750167827 @default.
• W3092804594 cites W2766722701 @default.
• W3092804594 cites W2793432989 @default.
• W3092804594 cites W2888562934 @default.
• W3092804594 cites W2893008696 @default.
• W3092804594 cites W2981764820 @default.
• W3092804594 doi "https://doi.org/10.1667/rade-20-00047.1" @default.
• W3092804594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33348375" @default.
• W3092804594 hasPublicationYear "2020" @default.
• W3092804594 type Work @default.
• W3092804594 sameAs 3092804594 @default.
• W3092804594 citedByCount "27" @default.
• W3092804594 countsByYear W30928045942021 @default.
• W3092804594 countsByYear W30928045942022 @default.
• W3092804594 countsByYear W30928045942023 @default.
• W3092804594 crossrefType "journal-article" @default.
• W3092804594 hasAuthorship W3092804594A5000702766 @default.
• W3092804594 hasAuthorship W3092804594A5023779644 @default.
• W3092804594 hasAuthorship W3092804594A5036656612 @default.
• W3092804594 hasAuthorship W3092804594A5044617172 @default.
• W3092804594 hasAuthorship W3092804594A5060298788 @default.
• W3092804594 hasAuthorship W3092804594A5060952463 @default.
• W3092804594 hasAuthorship W3092804594A5061274866 @default.
• W3092804594 hasAuthorship W3092804594A5067536094 @default.
• W3092804594 hasAuthorship W3092804594A5070908847 @default.
• W3092804594 hasAuthorship W3092804594A5073948949 @default.
• W3092804594 hasAuthorship W3092804594A5085287368 @default.
• W3092804594 hasConcept C111919701 @default.
• W3092804594 hasConcept C120665830 @default.
• W3092804594 hasConcept C121332964 @default.
• W3092804594 hasConcept C126838900 @default.
• W3092804594 hasConcept C153385146 @default.
• W3092804594 hasConcept C159317903 @default.
• W3092804594 hasConcept C187691185 @default.
• W3092804594 hasConcept C19527891 @default.
• W3092804594 hasConcept C2385561 @default.
• W3092804594 hasConcept C2524010 @default.
• W3092804594 hasConcept C2777152588 @default.
• W3092804594 hasConcept C2777526259 @default.
• W3092804594 hasConcept C2780387249 @default.
• W3092804594 hasConcept C2989005 @default.
• W3092804594 hasConcept C33923547 @default.
• W3092804594 hasConcept C41008148 @default.
• W3092804594 hasConcept C509974204 @default.
• W3092804594 hasConcept C71924100 @default.
• W3092804594 hasConcept C75088862 @default.
• W3092804594 hasConceptScore W3092804594C111919701 @default.
• W3092804594 hasConceptScore W3092804594C120665830 @default.
• W3092804594 hasConceptScore W3092804594C121332964 @default.

• next